Truvada Medication May Be Causing Kidney Failure and Bone Injuries

Truvada is an antiretroviral drug that that is prescribed for patients that have have a high risk of developing HIV.  The medication does not cure HIV or AIDS. It was intended to help improve the patients’ quality of life.  

Many persons have been harmed by Truvada by suffering from broken bones and/or kidney failure while taking the medication.  

Gilead Sciences, Inc., is the maker of Truvada and the company is now being sued by hundreds of people suffering from the side effects of taking the medication.  It has been reported that Gilead knew since the year 2000 that there was a safer alternative drug that they could have marketed called TAF. Despite early indicators that TAF offered a safer alternative, Gilead officials chose not to pursue development of the drug; critics say the company held the drug until it was strategically advantageous to release it.  By delaying the development of the TAF by a decade, Gilead extended its patent and market dominance until 2032.

If you or a loved one suffered from osteoporosis, brittle or broken bones, or kidney failure by taking Truvada, please call the experts at Inserra Kelley Sewell to see whether you might be entitled to compensation. 

Zantac Heartburn Medication Contains Cancer Carcinogens

On September 30, 2019, the FDA announced that ranitidine (Zantac), a heartburn medication used by millions of Americans, may cause cancer.  Zantac has been found to contain a carcinogenic chemical 26,000 times the FDA-approved limit.  When one 150 mg tablet is ingested, it undergoes a chemical reaction in the stomach to create more than 3,100 times the FDA-approved limit of N-nitrosodimethylamine (NDMA), a chemical which the FDA, EPA and World Health Organization classify as a dangerous carcinogen.

A newly filed class-action lawsuit accuses Sanofi, the maker of Zantac, of intentionally concealing risks of taking the medication to avoid sales and profit losses.  Zantac was first sold in starting in1983, and three years later it became the first drug to total $1 billion in annual sales. The Plaintiffs in the class-action lawsuit are from all over the United States, and many of them took Zantac daily for years.

On October 1, 2019, Walgreens and CVS Pharmacies suspended sales of Zantac and removed the product from their store shelves.

INSERRA l KELLEY l SEWELL wants you and yours to know that if you are taking Zantac, please consult with your physician to find out if you should immediately start taking an alternative medication.

If you or a loved one suffered from severe side effects or cancer from Zantac, please call the great mass tort Team at Inserra Kelley Sewell to see whether you might be entitled to compensation.